Duration of chronic cardiovascular disease or risk factor management studies identified in the DCP3 systematic review.

<p>Duration of chronic cardiovascular disease or risk factor management studies identified in the DCP3 systematic review.</p

Flow diagram describing the systematic literature review process.

<p>Flow diagram describing the systematic literature review process.</p

Study Characteristics (n = 49).

<p>Study Characteristics (n = 49).</p

Examples of acute phase CVD quality improvement interventions identified in the DCP3 systematic review.

<p>Types of interventions targeting three levels of acute phase CVD prevention and management. Bullets in bold type are supported by evidence from the review. Bullets without bold type indicate that no supporting evidence was found in the review and are potential areas for further research.</p

Quality conceptual framework for cardiovascular diseases, the DCP3.

<p>Quality conceptual framework for cardiovascular diseases, the DCP3.</p

System level-acute phase CVD quality improvement studies identified during review.

<p>System level-acute phase CVD quality improvement studies identified during review.</p

Patient/provider level-chronic phase CVD quality improvement studies identified during review.

<p>Patient/provider level-chronic phase CVD quality improvement studies identified during review.</p

Additional file 1: Figure S1. of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

Capability, opportunity, and motivation ratings of community members, non-physician health workers and doctors in 15 research projects at initial and subsequent assessment

Additional file 14: of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

PER 11 Assessment. Launching a Salt Substitute to Reduce Blood Pressure at the Population Level (PER 11)

Additional file 13: of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

FJI/WSM 10 Assessment. Cost Effectiveness of Salt Reduction Interventions in Pacific Islands (FJI/WSM 10)